SULFAMETHOXAZOLE; TRIMETHOPRIM | A077785 | CHARTWELL MOLECULAR HOLDINGS LLC
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Citizen Petition from Lachman Consultant Services, Inc. FDA-2019-P-0198 · 6 docket documents Lachman Consultant Services, Inc., acting as the US Agent for NaviSci Pte Ltd, filed this petition requesting that the FDA designate an additional reference standard for Sulfamethoxazole and Trimethoprim Oral Suspension in the Orange Book to support an ANDA submission, citing that the current refere | Other | 2019-01-14 | DeniedUnverified summary | Lachman Consultant Services, Inc. |
Source: Regulations.gov. FDA citizen petitions matched by application number.
Highest NADAC/Unit
$0.0551
per ml
Lowest NADAC/Unit
$0.0551
per ml
Brand NDCs
0
Generic NDCs
1
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 62135074947SULFAMETHOXAZOLE-TMP SUSP | $0.0551 | ML | Generic | — | 2026-08-19 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.